Article info

Download PDFPDF

Hyperbaric oxygen as an adjuvant treatment for patients with COVID-19 severe hypoxaemia: a randomised controlled trial

Authors

  • Mariana Cannellotto Research Department, Argentine Association of Hyperbaric Medicine and Research (AAMHEI), Buenos Aires, Argentina PubMed articlesGoogle scholar articles
  • Mariano Duarte Laboratory of Arterial Hypertension, Cardiology Department, Hospital de Clinicas Jose de San Martin, Buenos Aires, ArgentinaSegunda Cátedra de Fisiología, Universidad de Buenos Aires Facultad de Medicina, Buenos Aires, Argentina PubMed articlesGoogle scholar articles
  • Guillermo Keller Instituto Alberto C Taquini de Investigaciones en Medicina Traslacional - Facultad de Medicina, Universidad de Buenos Aires and CONICET, Buenos Aires, ArgentinaGeneral Medicine, Hospital General de Agudos Donación Santojanni, Buenos Aires, Federal District, ArgentinaTercera Cátedra de Farmacología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina PubMed articlesGoogle scholar articles
  • Ramiro Larrea General Medicine, Municipal Hospital of San Isidro, San Isidro, Argentina PubMed articlesGoogle scholar articles
  • Eleonora Cunto Intensive Care Unit, Hospital de Infecciosas Dr Francisco Javier Muñiz, Buenos Aires, Argentina PubMed articlesGoogle scholar articles
  • Viviana Chediack Intensive Care Unit, Hospital de Infecciosas Dr Francisco Javier Muñiz, Buenos Aires, Argentina PubMed articlesGoogle scholar articles
  • Mariela Mansur General Medicine, Municipal Hospital of San Isidro, San Isidro, Argentina PubMed articlesGoogle scholar articles
  • Daniela M Brito General Medicine, Municipal Hospital of San Isidro, San Isidro, Argentina PubMed articlesGoogle scholar articles
  • Elizabeth García General Medicine, Hospital General de Agudos Donación Santojanni, Buenos Aires, Federal District, Argentina PubMed articlesGoogle scholar articles
  • Héctor E Di Salvo General Medicine, Hospital General de Agudos Donación Santojanni, Buenos Aires, Federal District, Argentina PubMed articlesGoogle scholar articles
  • Fabrizio Verdini Research Department, Argentine Association of Hyperbaric Medicine and Research (AAMHEI), Buenos Aires, Argentina PubMed articlesGoogle scholar articles
  • Cecilia Domínguez Intensive Care Unit, Hospital de Infecciosas Dr Francisco Javier Muñiz, Buenos Aires, Argentina PubMed articlesGoogle scholar articles
  • Liliana Jorda-Vargas Research Department, Argentine Association of Hyperbaric Medicine and Research (AAMHEI), Buenos Aires, Argentina PubMed articlesGoogle scholar articles
  • Javier Roberti Qualitative Research in Health, Institute for Clinical Effectiveness and Health Policy, Buenos Aires, ArgentinaCentre for Research on Epidemiology and Public Health (CIESP), CONICET, Buenos Aires, Argentina PubMed articlesGoogle scholar articles
  • Guillermo Di Girolamo Instituto Alberto C Taquini de Investigaciones en Medicina Traslacional - Facultad de Medicina, Universidad de Buenos Aires and CONICET, Buenos Aires, ArgentinaTercera Cátedra de Farmacología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina PubMed articlesGoogle scholar articles
  • Esteban Estrada Research Department, Argentine Association of Hyperbaric Medicine and Research (AAMHEI), Buenos Aires, ArgentinaHyperbaric Medicine, Hospital Alta Complejidad JD Perón, Formosa, Argentina PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Javier Roberti, Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina; javierroberti{at}gmail.com
View Full Text

Citation

Cannellotto M, Duarte M, Keller G, et al
Hyperbaric oxygen as an adjuvant treatment for patients with COVID-19 severe hypoxaemia: a randomised controlled trial

Publication history

  • Received February 1, 2021
  • Accepted October 14, 2021
  • First published December 14, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.